| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |